XML 90 R81.htm IDEA: XBRL DOCUMENT
v3.23.1

JOINT VENTURES AND ASSOCIATES (Details) - USD ($) |  | 3 Months Ended | 9 Months Ended |
--- | --- | --- | --- | ---
Dec. 28, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Jun. 30, 2022
JOINT VENTURES |  |  |  |  |  |
Assets in joint ventures and associates |  | $ 39,185,745 |  | $ 39,185,745 |  | $ 38,554,092
Liabilities in joint ventures and associates |  | 221,014 |  | 221,014 |  | 717,948
Share of profit or loss of joint ventures and associates |  | 378,145 | $ (203,954) | 1,260,433 | $ 715,133 |
Trigall Genetics S.A. |  |  |  |  |  |
JOINT VENTURES |  |  |  |  |  |
Liabilities in joint ventures and associates |  | 221,014 |  | 221,014 |  | 717,948
Share of profit or loss of joint ventures and associates |  |  |  | 496,934 | 828,307 |
Synertech Industrias S.A. |  |  |  |  |  |
JOINT VENTURES |  |  |  |  |  |
Assets in joint ventures and associates |  | 35,892,032 |  | 35,892,032 |  | 35,646,740
Share of profit or loss of joint ventures and associates |  |  |  | 337,543 | (48,882) |
Indrasa Biotecnologia S.A. |  |  |  |  |  |
JOINT VENTURES |  |  |  |  |  |
Assets in joint ventures and associates |  |  |  |  |  | 70,466
Share of profit or loss of joint ventures and associates |  |  |  | (57,033) | 50,417 |
Alfalfa Technologies S.R.L |  |  |  |  |  |
JOINT VENTURES |  |  |  |  |  |
Assets in joint ventures and associates |  | 44,840 |  | 44,840 |  | 74,827
Moolec Science Limited |  |  |  |  |  |
JOINT VENTURES |  |  |  |  |  |
Assets in joint ventures and associates |  |  |  |  |  | 2,759,059
Share of profit or loss of joint ventures and associates |  |  |  |  | $ (114,709) |
Moolec Science S.A. |  |  |  |  |  |
JOINT VENTURES |  |  |  |  |  |
Assets in joint ventures and associates |  | $ 3,248,873 |  | 3,248,873 |  | $ 3,000
Share of profit or loss of joint ventures and associates |  |  |  | $ 482,989 |  |
Moolec Science S.A. | Ordinary shares |  |  |  |  |  |
JOINT VENTURES |  |  |  |  |  |
Number of shares received in exchange for all of its ownership in Moolec Sciente Limited ordinary shares | 1,560,000 |  |  |  |  |
Ownership held (in shares) |  | 1,860,000 |  | 1,860,000 |  |

X
- Definition The number of shares received from joint ventures in exchange for consideration contributed. + References No definition available. + Details
Name: | biox_InvestmentInJointVenturesNumberOfSharesReceived
Namespace Prefix: | biox_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of investments accounted for using the equity method, asset position. + References No definition available. + Details
Name: | biox_InvestmentsAccountedForUsingEquityMethodAssets
Namespace Prefix: | biox_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of investments accounted for using the equity method, liability position. + References No definition available. + Details
Name: | biox_InvestmentsAccountedForUsingEquityMethodLiability
Namespace Prefix: | biox_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of shares of the joint ventures held by the entity at reporting date. + References No definition available. + Details
Name: | biox_JointVentureNumberOfSharesHeld
Namespace Prefix: | biox_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfJointVenturesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2022-03-24 -Paragraph 28 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_e&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2022-03-24 -Paragraph 23 -Subparagraph g -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_g&doctype=Standard -URIDate 2022-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective on first application of IFRS 9 -Name IFRS -Number 4 -IssueDate 2022-03-24 -Paragraph 39M -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39M_b&doctype=Standard -URIDate 2022-03-24 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 82 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_c&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_TrigallGeneticsS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_SynertechIndustriasS.aMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_IndrasaBiotecnologaS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_AlfalfaTechnologiesS.r.lMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_MoolecScienceLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_MoolecScienceS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |